In agreement with a potential pro-inflammatory role of 3-hydroxydecanoate signaling through GPR84, antagonists to this receptor were previously demonstrated to inhibit neutrophil migration and inflammation in acute liver injury38 as well as in an inflammatory bowel disease model in mice.37 The gene discussed is GPR84; the disease is inflammatory bowel disease.